$IBTA

Leach Bryan sold $771K of IBTA

Leach Bryan (CEO AND PRESIDENT) sold 21,895 shares of Ibotta, Inc. (IBTA) at an average of $35.21 ($34.63–$35.79, $0.77M total) across 4 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Leach Bryan
Published Jul 6, 2026, 9:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
high confidence
Mentioned
$IBTA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The newest information is the disclosed sale size, dates, and weighted-average prices; it may influence short-term sentiment but does not, by itself, change fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but the pre-arranged nature and lack of other catalysts keep the signal modest.

03

What to watch

The article provides only the sale details; it does not state whether there were concurrent purchases, changes in guidance, or other catalysts that would contextualize the selling.

Relevance 4/10Novelty 3/10Timing: Filed on 2026-07-06 after sales dated 2026-07-01 to 2026-07-02.

Background

This is an SEC Form 4 insider transaction: CEO/president Leach Bryan sold IBTA shares in multiple trades under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$IBTANeutralHigh confidence
Context

Ibotta CEO Leach Bryan sold about $770.8K of IBTA shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived around insider-selling headlines.

Evidence & confidence

The filing is a disclosed open-market sale by the CEO under a pre-arranged 10b5-1 plan, with no accompanying operational/regulatory/financial catalyst in the text.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still be read by some traders as confidence erosion, especially if paired with other negative signals (not present here).

Key entities

  • Ibotta, Inc.

    Public company subject of the Form 4 insider sale disclosure (IBTA).

  • Leach Bryan

    CEO and President; reported open-market sales under a 10b5-1 plan.

Related articles

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease63026.htm EX-99.1 Document Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million